Medical Device News Magazine

Bluejay Diagnostics Allereye Tear Total IgE Test Receives CE Mark

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...


  • Developed on a unique design and technology platform, Allereye offers non-invasive and rapid (15 minutes) POC detection of IgE in the aid to diagnose allergic reactions in the eye.

Bluejay Diagnostics announced that it has received CE Mark for the Allereye Tear Total IgE Test.  Allereye, an FDA-Cleared point-of-care (POC) device, offers healthcare providers a cost-effective, non-invasive, reliable, easy-to-use solution to aid in the diagnosis of allergic conjunctivitis. Bluejay expects to launch the product in Q2 of 2019 throughout Europe and the Middle East.

Allereye confirms the presence of total IgE in tears. Developed on a unique design and technology platform, Allereye offers non-invasive and rapid (15 minutes) POC detection of IgE in the aid to diagnose allergic reactions in the eye. Such detection at point-of-care might prevent unnecessary dry-eye treatment and unnecessary antibiotic regimen.

Svetlana Dey, President of Bluejay, added, “After receiving very positive feedback from U.S. clinicians and patients, we are confident that Allereye will bring the same value to the patient population throughout Europe and the Middle East.”

Interest in conjunctivitis commonly known as ‘red-eye’ has increased in recent years due to its growing prevalence, increasing healthcare costs, and its impact on patient quality of life. Often allergic, viral, and bacterial related ‘red-eye’ have similar symptoms leading to an inaccurate diagnosis more than half of the time and resulting in unnecessary time away from work, school and play.

Currently about two out of every five people worldwide suffer from allergic conjunctivitis. Itchy eyes are the most common symptom. Seasonal allergic conjunctivitis is the most common form as symptoms are associated with specific aeroallergens. Perennial allergic conjunctivitis persists throughout the year and is often caused by dust mites, molds and pet dander.

Medical Device News Magazine
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

HeartFlow Introduces Next Generation Interactive Plaque Analysis Platform to Assess Patient Risk in Suspected Coronary Artery Disease

The HeartFlow Plaque Analysis uses proprietary algorithms to analyze coronary CT angiogram (CCTA) scans, creating a personalized 3D model that quantifies and characterizes plaque volume in the coronary arteries, aiding risk assessment of coronary artery disease. The technology was introduced at the Society of Cardiovascular Computed Tomography (SCCT) Annual Scientific Meeting in Washington, D.C.

Ultrahuman Announces its App Store ‘PowerPlugs’ with the World’s First AFib Detection Technology on a Smart Ring

Recognizing each individual’s health journey is unique, PowerPlugs enable people to choose and focus on the aspects of their health that matter most. It’s designed for highly personalized health insights, ensuring that every individual can personalize their health tracking to their unique needs and goals.

VisionAir Solutions Celebrates Milestone and New Collaboration

This achievement marks VisionAir Solutions commitment to bringing technological innovation to pulmonary medicine. Since its acquisition by Theken Companies last year, VAS has over doubled its growth and continues to demonstrate industry adoption and the advantages of personalized healthcare.